CSL:ASX
CSL Ltd
A$167.10
arrow_downward
-1.42%(-2.40) 1D
Sep 11, 4:10:14 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSL...
Open
A$167.00
High
A$169.36
Low
A$165.79
Mkt. cap
80.17B
Avg. vol.
1.41M
Volume
806.57K
Dividend
1.69%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 9, 2026
52-wk high
A$222.47
52-wk low
A$90.00
EPS
-A$7.42
Shares outstanding
479.88M
No. of employees
29K
Open
A$167.00
High
A$169.36
Low
A$165.79
Mkt. cap
80.17B
Avg. vol.
1.41M
Volume
806.57K
Dividend
1.69%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 9, 2026
52-wk high
A$222.47
52-wk low
A$90.00
EPS
-A$7.42
Shares outstanding
479.88M
No. of employees
29K
News stories
From web sources and news partners
Kalkine Media
·
7 hours ago
What Could CSL Limited (ASX:CSL) Mean for ASX Technical Analysis Stocks?
Kalkine Media
·
7 hours ago
Why Is CSL (ASX:CSL) in Focus in ASX Healthcare Stocks?
Rask Media
·
1 day ago
A deep dive into CSL shares
Kalkine Media
·
1 day ago
CSL (ASX:CSL): Can stabilise after its earnings reset?
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com